CEP-33779 (CAS: 1257704-57-6) is a novel, selective, and orally bioavailable inhibitor of JAK2 with IC50 of 1.8 nM. CEP-33779 induced regression of established colorectal tumors, reduced angiogenesis, and reduced proliferation of tumor cells.

Products > JAK/STAT Signaling > JAK > CEP-33779 (CEP33779. CEP 33779)

Product name : CEP-33779 (CEP33779. CEP 33779)

Product No. : cs-1066

Price : 100mg, $675, 500mg/$1875

CAS :

Bulk inquiry :

←[Previous Product] [Next Product]→

Online Inquiry Email Us

Details:

CEP-33779 (CAS: 1257704-57-6) is a novel, selective, and orally bioavailable inhibitor of JAK2 with IC50 of 1.8 nM. CEP-33779 induced regression of established colorectal tumors, reduced angiogenesis, and reduced proliferation of tumor cells.

Related Products :

GLPG0634 analog
Price: 50mg, $675; 100mg, $1175

BMS-911543 (BMS911543, BMS 911543)
Price: 100mg, $675, 500mg/$1875

GLPG0634 (analog)
Price: 100mg, $675, 500mg/$1875

Decernotinib (VX-509; VX509; VX 509; VRT-831509)
Price: 100mg, $675, 500mg/$1875

Peficitinib (ASP-015K, ASP015K, JNJ-54781532, JNJ54781532)
Price: 100mg/$675, 500mg/$1875

JANEX-1 (WHI-P131)
Price: 100mg/$675; 500mg/$1875

Cerdulatinib (PRT062070; PRT2070; PRT-062070; PRT-2070; PRT 062070; PRT 2070)
Price: 100mg, $475, 500mg/$1275

JAK2 Inhibitor V, Z3 (NSC-42834, NSC42834, NSC 42834)
Price: 100mg, $975, 500mg/$2475

cckinase, Inc.